VEGFA and cancer: TIMPs, in addition to inhibiting MMPs, are also assumed to participate in processes involved in cancer progression and metastasis; in particular, they have been found to inhibit angiogenesis by selectively blocking the action of various growth factors, such as fibroblast growth factor 2 and vascular endothelial growth factor A (VEGF-A) [30].